Lipidomics Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Lipidomics Market by Sample Type (Blood Sample, Tissue Sample, Others) By lipid source (Human Source, Animal Source, Plant Source), By Application (Drug Discovery, Biomarker Discovery, Personalized Medicine, Diagnosis and Treatment, Others), By End-user (Biopharmaceutical Companies, Agriculture Industries, Food and Beverage Industries, Academic Research Institutes) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties. Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the market growth over the forecast period. The research includes detailed information on developing trends, market drivers, development opportunities, and market restraints that may affect the industry’s market dynamics. It includes a product, application, and competition analysis, as well as an in-depth examination of the market segments. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.

Key Developments:

In July 2020, Croda International Plc (‘Croda’) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.

 


MARKET SUMMARY
-
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– %
  • Largest Market– North America
  • Fastest Growing Market– Europe

Lipidomics Market

  • The report on lipidomics market gives historical, current, and future market sizes of sample type, service type, lipid source, application, end user and geographic regions.
  • Lipidomics Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Zora Biosciences Oy (Finland)
  • OWL Metabolomics (Spain)
  • ProSciento (U.S.)
  • Avanti Lipids Polar, Inc. (U.S.)
  • VCU Massey Cancer Center (U.S.)
  • Lipotype GmbH (Germany)
  • Metabolon, Inc. (U.S.)
  • Waters Corporation (U.S.)
  • Lipotype GmbH (Germany)
Growth

Lipidomics Market

The rise in need for precise illness diagnosis, the rise in demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. However, the lipidomics market’s growth is hampered by strict regulatory constraints, a lack of modern instruments, a lack of technology acceptance, and a scarcity of professional researchers.


North-America Got Significant Share

North America estimated to account for significant revenue share in global services market owing to huge number of bio pharmaceutical companies focused on the R&D activities of lipidomics, rise in funds from the government organizations, and availability of professional researchers and well-established infrastructure. Europe is expected to expand at significant growth rate due to high adoption of novel technologies; researchers and governments concentrated on prevention of genetic disorders, and increase in target disease conditions. Moreover, increase in population and birth rate, rise in prevalence of diabetes and other targeted diseases, increase in R&D activities in China, Japan, and India, rise in demand for personalized medicine in Asia-Pacific region expected to create significant opportunities for the market over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In September 2016, Lipotype GmbH launched its novel Lipotype shot gun skin lipidomics technology.
  • In June 2015, SCIEX a lifescience analytical technologies company and Metabolon a lipidomics company entered into a multi-year collaboration, and they released The Lipidizer Platform, aan integrated solution for accurate next generation lipidomics.

Key

Key Features of the Report

Lipidomics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Zora Biosciences Oy (Finland)
  • OWL Metabolomics (Spain)
  • ProSciento (U.S.)
  • Avanti Lipids Polar, Inc. (U.S.)
  • The Metabolomics Innovation Centre (U.S.)
  • VCU Massey Cancer Center (U.S.)
  • Virginia Commonwealth University (U.S.)
  • Lipotype GmbH (Germany)
  • School of Medicine (Wayne State University) (U.S.)
  • Metabolon, Inc. (U.S.)
  • Waters Corporation (U.S.)
  • Lipotype GmbH (Germany)

Description

Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties. Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the market growth over the forecast period. The research includes detailed information on developing trends, market drivers, development opportunities, and market restraints that may affect the industry’s market dynamics. It includes a product, application, and competition analysis, as well as an in-depth examination of the market segments. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.

Key Developments:

In July 2020, Croda International Plc (‘Croda’) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX